SCHEMBL2844835

SCHEMBL2844835

O=C(O)C1=C2Cc3ccccc3N2C=CC=C1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 4/20 0.36
TSHR P16473 2/20 0.36
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
KDM4E B2RXH2 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NPC1 O15118 2/20 0.33
TP53 P04637 2/20 0.33
NFKB1 P19838 2/20 0.33
RAB9A P51151 2/20 0.33
NFKB2 Q00653 2/20 0.33
RELA Q04206 2/20 0.33
MAPK1 P28482 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2851137 0.80 MEN1 (0.36) NOTUMMEN1KMT2AMAPK1
SCHEMBL16972705 0.68 NOTUM (0.38) NOTUMTSHRALDH1A1HPGDMAPT
SCHEMBL15063574 0.67 POLB (0.32) POLBTDP1
SCHEMBL5253272 0.67 NOTUM (0.35) NOTUMTSHRALDH1A1HPGDMAPT
SCHEMBL3211485 0.63 HPGD (0.33) NOTUMTSHRALDH1A1HPGDMEN1
SCHEMBL30417865 0.63 HPGD (0.45) NOTUMTSHRALDH1A1HPGDMAPT
SCHEMBL1515682 0.62 NOTUM (0.36) NOTUMTSHRALDH1A1HPGDMAPT
SCHEMBL6430846 0.62 SIGMAR1 (0.30)
SCHEMBL27489322 0.61 NOTUM (0.56) NOTUMTSHRALDH1A1HPGDMAPT
SCHEMBL3715231 0.58 NOTUM (0.46) NOTUMTSHRALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010003658-A1 MACROCYCLIC INDOLE DERIVATIVES USEFUL AS HEPATITIS C VIRUS INHIBITORS TIBOTEC PHARMACEUTICALS (IE) 2010-01-14 WO disclosed
EP-1776368-A1 INHIBITORS OF HCV REPLICATION Bristol-Myers Squibb Company (US) 2007-04-25 EP disclosed
WO-2006020082-A1 INHIBITORS OF HCV REPLICATION BRISTOL-MYERS SQUIBB COMPANY (US) 2006-02-23 WO disclosed